HOOK

HOOKIPA Pharma Inc.

0.78 USD
+0.01 (+1.42%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

HOOKIPA Pharma Inc. stock is up 14.85% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 March’s closed higher than February.

About HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc. develops immunotherapeutics targeting infectious diseases and cancers. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers.